Anne Louise Marano

Study of autoimmune skin disease
Specialty autoimmune skin disease clinic 1 half day per week

Clinical retrospective studies, case series, and participation in clinical trials and regisitries for autoimmune skin disease including connective tissue disease, autoimmune blistering disease, and sarcoidosis

Principal Investigator on Viela Bio Duke IRB Pro00102079, Study Title: “A Phase 1 Randomized, Placebo-Controlled, Blinded, Multiple Ascending Dose Study to Evaluate VIB7734 in Systemic Lupus Erythematosus, Cutaneous Lupus Erythematosus, Sjogren’s Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis

Subinvestigator on Duke IRB Pro00084622, Study Title “Retrospective Study evaluating cutaneous problems among immunocompromised patients (i.e. autoimmune disease, hematologic and solid organ malignancies and Hematopoetic Stem Cell Transplant (HSCT)”

Subinvestigator on Duke IRB Pro00048083, Study Title “Autoantibodies in Autoimmune Skin Disease”

Subinvestigator on Duke IRB Pro00106752, Study Title “Cutaneous Sarcoidosis Registry”

Subinvestigator on Duke IRB Pro00106917/ Pro00107123, Study Title “A Randomized, Double-Blinded, Placebo-Controlled Trial to Investigate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 SC in Adult Patients With Pemphigus (Vulgaris or Foliaceus) (ADDRESS)”